1996
DOI: 10.1016/0003-4975(95)01018-1
|View full text |Cite
|
Sign up to set email alerts
|

Small, low-cost implantable centrifugal pump for short-term circulatory assistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
10
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 8 publications
0
10
0
Order By: Relevance
“…Although elevated pulmonary vascular resistance did not correlate with reduced pRVSD flow in this study, continuous-flow devices are known to be subject to the effects of increased afterload. 19 Contemporary algorithms for the management of RVF focus on reversing the underlying cause of RVF, maintaining adequate preload with volume resuscitation, reducing RV afterload with inhaled nitric oxide, and enhancing RV contractility with inotropes. In primary RV systolic dysfunction, maintaining low pulmonary vascular resistance, with or without augmenting RV contractility through inotropes, often provides adequate hemodynamic support.…”
Section: Discussionmentioning
confidence: 99%
“…Although elevated pulmonary vascular resistance did not correlate with reduced pRVSD flow in this study, continuous-flow devices are known to be subject to the effects of increased afterload. 19 Contemporary algorithms for the management of RVF focus on reversing the underlying cause of RVF, maintaining adequate preload with volume resuscitation, reducing RV afterload with inhaled nitric oxide, and enhancing RV contractility with inotropes. In primary RV systolic dysfunction, maintaining low pulmonary vascular resistance, with or without augmenting RV contractility through inotropes, often provides adequate hemodynamic support.…”
Section: Discussionmentioning
confidence: 99%
“…The flow of centrifugal pumps 12,13 or axial pumps 14,15 used as LVADs is affected by the pressure gradient between inflow and outflow. Therefore, it is essential to maintain low or normal systemic vascular resistance for patients supported by these pumps.…”
Section: Discussionmentioning
confidence: 99%
“…Acute heart failure, cardiogenic shock, cardiac surgery and rehabilitation are candidate diseases in the use of VADs. In the past decades, several VADs have being developed [3][4][5]. A specific design of VADs was recently reported by Sacristan et al which has been tested in vitro and in vivo with satisfactory hydrodynamic and hemodynamic results [5][6][7].…”
Section: Introductionmentioning
confidence: 97%